Insulet Corp

More Details of Insulet Corp Company

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Company Info

Company codePODD

Company nameInsulet Corp

IPO dateMay 15, 2007

Founded at2000

CEOMs. Ashley Mcevoy

Number of employees3900

Security typeOrdinary Share

Fiscal year-endMay 15

Address100 Nagog Park

CityACTON

Stock exchangeNASDAQ Global Select Consolidated

CountryUnited States of America

Postal code01720-3440

Phone19786007000

Websitehttps://www.omnipod.com

Company codePODD

IPO dateMay 15, 2007

Founded at2000

Company Executives

Name

Name/Position

Position

Shareholding

Change

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

4.46K

--

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

+24.38%

Dr. Luciana Borio, M.D.

Independent Director

2.79K

--

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.12K

+53.26%

Name

Name/Position

Position

Shareholding

Change

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

By BusinessUSD

Name

Revenue

Proportion

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

By RegionUSD

Name

Revenue

Proportion

United States

1.55B

74.73%

All Other

523.40M

25.27%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

Shareholder

Update time: Fri, Feb 21

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

Type

Shareholder

Proportion

Investment Advisor

55.61%

Investment Advisor/Hedge Fund

35.89%

Hedge Fund

3.60%

Research Firm

2.91%

Pension Fund

1.75%

Sovereign Wealth Fund

1.43%

Bank and Trust

1.36%

Private Equity

0.33%

Individual Investor

0.28%

Institutional Shareholding

Update time: Mon, Jan 20

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

1508

72.93M

103.85%

-4.38M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

2023Q1

1206

74.71M

107.20%

-300.49K

2022Q4

1126

71.74M

103.30%

-3.89M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

8.46M

12.05%

+16.65K

+0.20%

Dec 31, 2024

Capital Research Global Investors

7.45M

10.6%

-326.10K

-4.20%

Dec 31, 2024

Fidelity Management & Research Company LLC

7.08M

10.08%

-246.09K

-3.36%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

4.25M

6.05%

+74.08K

+1.77%

Dec 31, 2024

State Street Global Advisors (US)

2.97M

4.24%

+59.55K

+2.04%

Dec 31, 2024

Baillie Gifford & Co.

2.36M

3.35%

+79.98K

+3.51%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.78M

2.53%

+40.57K

+2.33%

Dec 31, 2024

Fidelity International

1.43M

2.04%

-9.70K

-0.67%

Dec 31, 2024

ClearBridge Investments, LLC

1.41M

2%

-62.73K

-4.27%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

953.02K

1.36%

-911.00

-0.10%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

Langar Global HealthTech ETF

6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

5.13%

Goldman Sachs Future Health Care Equity ETF

4.71%

Global X Telemedicine & Digital Health ETF

4.21%

Fidelity Digital Health ETF

3.91%

Congress SMid Growth ETF

2.6%

Harbor Health Care ETF

2.32%

iShares U.S. Medical Devices ETF

2.03%

First Trust Health Care Alphadex Fund

1.8%

iShares Health Innovation Active ETF

1.76%

Langar Global HealthTech ETF

Proportion6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proportion5.13%

Goldman Sachs Future Health Care Equity ETF

Proportion4.71%

Global X Telemedicine & Digital Health ETF

Proportion4.21%

Fidelity Digital Health ETF

Proportion3.91%

Congress SMid Growth ETF

Proportion2.6%

Harbor Health Care ETF

Proportion2.32%

iShares U.S. Medical Devices ETF

Proportion2.03%

First Trust Health Care Alphadex Fund

Proportion1.8%

iShares Health Innovation Active ETF

Proportion1.76%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

251.485USD

Insulet Corp

251.485

Overview

Company